Catalyst is a clinical research organization (CRO) that provides highly customizable solutions to the global biopharmaceutical industry through two established, branded solutions: Catalyst Oncology and Catalyst Flex The company provides multi-therapeutic global resourcing and functional services through Catalyst Flex, and full-service oncology CRO offerings through Catalyst Oncology. With over 800 staff and offices in the United States, United Kingdom, and Europe, Catalyst’s flexible service model is built from more than a decade of listening to customers, devising customer-centric solutions, and helping customers drive breakthrough clinical studies by leveraging expert teams and innovative technologies. Visit Catalyst online at CatalystCR.com. Follow us on Facebook, Twitter, and LinkedIn: @CatalystCR. 

Catalyst is a portfolio company of QHP Capital, a leading healthcare and life sciences investment firm.